within Pharmacolibrary.Drugs.ATC.P;

model P03BX05
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.5,
    Cl             = 0.08333333333333333,
    adminDuration  = 600,
    adminMass      = 0.5,
    adminCount     = 1,
    Vd             = 0.035,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0008333333333333334,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Dimethylcarbate is an organocarbamate compound formerly used as an anthelmintic for the treatment of parasitic worm infections in humans and animals. It is no longer widely used or approved for medical use in most countries.</p><h4>Pharmacokinetics</h4><p>No published pharmacokinetic data specific to humans or animals for dimethylcarbate is available in the scientific literature.</p><h4>References</h4><ol><li>Alexander N Shikov, Elena V Flisyuk, Ekaterina D Obluchinskaya, Olga N Pozharitskaya,Pharmacokinetics of Marine-Derived Drugs.,Marine drugs,2020<a href='https://pubmed.ncbi.nlm.nih.gov/33182407/'>https://pubmed.ncbi.nlm.nih.gov/33182407/</a></li><li>Hannah Katharine Batchelor, John Francis Marriott,Paediatric pharmacokinetics: key considerations.,British journal of clinical pharmacology,2015<a href='https://pubmed.ncbi.nlm.nih.gov/25855821/'>https://pubmed.ncbi.nlm.nih.gov/25855821/</a></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end P03BX05;
